CIK 0001159036 · Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880488686
- Phone
- (858) 794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,884,955
- in 5 filings, $19.9M under 10b5-1 plans
Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-01 | Duncan Barbara Gayle Director | Grant or award | +4,165 | 19,919 | ||
| 2025-05-01 | Duncan Barbara Gayle Director | Grant or award · Option to Purchase Common Stock | +5,750 | 5,750 | ||
| 2025-05-01 | Connaughton Bernadette Director | Grant or award | +4,165 | 50,952 | ||
| 2025-05-01 | Connaughton Bernadette Director | Grant or award · Option to Purchase Common Stock | +5,750 | 5,750 | ||
| 2025-04-28 | Henderson Jeffrey William Director | Sale 10b5-1 | −4,297 | $60.34 | $259K | 28,811 |
| 2025-04-28 | Henderson Jeffrey William Director | Sale 10b5-1 | −200 | $61.00 | $12K | 28,611 |
| 2025-04-01 | Henderson Jeffrey William Director | Sale 10b5-1 | −503 | $64.05 | $32K | 33,108 |
| 2025-03-03 | Henderson Jeffrey William Director | Sale 10b5-1 | −1,795 | $57.93 | $104K | 36,816 |
| 2025-03-03 | Henderson Jeffrey William Director | Sale 10b5-1 | −3,205 | $59.12 | $189K | 33,611 |
| 2025-02-27 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −1,597 | $58.25 | $93K | 173,856 |
| 2025-02-27 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −100 | $58.74 | $6K | 173,756 |
| 2025-02-26 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −9,400 | $58.09 | $546K | 176,053 |
| 2025-02-26 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −600 | $58.65 | $35K | 175,453 |
| 2025-02-25 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −9,300 | $58.01 | $539K | 186,153 |
| 2025-02-25 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −700 | $58.67 | $41K | 185,453 |
| 2025-02-23 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Option exercise | +4,747 | 197,863 | ||
| 2025-02-23 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Shares withheld for taxes | −2,410 | $57.75 | $139K | 195,453 |
| 2025-02-23 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Option exercise · Restricted Stock Units | −4,747 | 14,238 | ||
| 2025-02-23 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Option exercise | +7,012 | 32,264 | ||
| 2025-02-23 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Shares withheld for taxes | −3,775 | $57.75 | $218K | 28,489 |
Page 19 of 26 · 513 trades